Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 109, Issue 2, Pages 363-374Publisher
WILEY
DOI: 10.1002/jcb.22410
Keywords
HUMAN EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; SMOOTH MUSCLE CELLS; BMP4; TGF beta
Categories
Funding
- National Institute of Health [K01DK064696, 2P20RR18789]
- American Society of Hematology Junior Faculty Scholar Award
Ask authors/readers for more resources
The signals that direct pluripotent stem cell differentiation into lineage-specific cells remain largely Unknown. Here, we investigated the roles of BMP on vascular progenitor development from human embryonic stem cells (hESCs). In a serum-free condition, hESCs sequentially differentiated into CD34+CD31-, CD34-CD31+, and then CD34-CD31+ cells during vascular cell development. CD34+CD31+ cells contained vascular progenitor population that gives rise to endothelial cells and smooth muscle cells. BMP4 promoted hESC differentiation into CD34+CD31+ cells at all early stage. In contrast, TGF beta suppressed BMP4-induced CD34+CD31+ cell development, and promoted CD34+CD31+ cells that failed to give rise to either endothelial or smooth muscle cells. The BMP-Smad inhibitor, dorsomorphin, inhibited phosphorylation of Smad 1/5/8, and blocked hESC differentiation to CD34+CD31+ progenitor cells, suggesting that BMP Smad-dependent signaling is critical for CD34+CD31+ vascular progenitor development. Our Findings provide new insight into how, pluripotent hESCs differentiate into vascular cells. J. Cell. Biochem. 109: 363-374, 2010. (C) 2009 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available